CD8A and prostate cancer: For example, LncRNA KCNQ1OT1 inhibits the cytotoxicity of CD8+ T cells and promotes the malignant ability of prostate cancer cells by targeting miR-15a/PD-L1 axis (Chen et al., 2020).